Increased levels of angiogenic factors such as soluble endoglin and increased ratios of soluble Fms-like tyrosine kinase 1: placental growth factor have been identified as clinically useful predictive and diagnostic biomarkers in the development of preeclampsia however to date no specific markers for future CVD risk has been identified [23]. This evidence concerns the gene PGF and preeclampsia.